Cite Filings / MDGL / 0001950047-25-001566
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

MADRIGAL PHARMACEUTICALS, INC. · Filed 2025-03-05 · Acc 0001950047-25-001566

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2025-03-12 144 Sale of Securities
  • 2025-03-05 144 Sale of Securities
  • 2025-03-05 4 General Counsel sold 415 shares at $335.00 ($139,025)
  • 2025-03-05 4 SVP and CFO sold 1,961 shares at an average $324.96 ($637,248)
  • 2025-03-05 4 Chief Commercial Officer sold 1,834 shares at an average $325.98 ($597,840)
  • 2025-03-04 4 Senior VP, Chief Pharma Dev. sold 1,227 shares at an average $341.07 ($418,488)
  • 2025-03-03 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…